XKRX014440
Market cap48mUSD
Jan 10, Last price
3,680.00KRW
1D
0.55%
1Q
8.24%
Jan 2017
-43.30%
Name
Youngbo Chemical Co Ltd
Chart & Performance
Profile
Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artiflex, artilon, epilon, heatlon, filmy, polyisocyanurate, and youngboard cross-linked polyolefin foam products. Its products are used in various applications, including automotive interior, home appliance and HVAC/climate control, building and construction, sports and leisure, packaging and cushioning, sundry goods and others, specialty products, IT parts materials, sound absorption materials, electronic materials, and wallpaper products. The company was founded in 1979 and is headquartered in Chungju-si, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 90,279,030 8.78% | 82,988,930 -16.80% | |||||||
Cost of revenue | 74,733,453 | 67,830,693 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 15,545,577 | 15,158,237 | |||||||
NOPBT Margin | 17.22% | 18.27% | |||||||
Operating Taxes | 915,546 | 414,994 | |||||||
Tax Rate | 5.89% | 2.74% | |||||||
NOPAT | 14,630,031 | 14,743,243 | |||||||
Net income | 5,960,795 -10.89% | 6,689,329 91.03% | |||||||
Dividends | (975,000) | (1,950,000) | |||||||
Dividend yield | 1.33% | 2.92% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 2,197,480 | 9,701,944 | |||||||
Long-term debt | 195,920 | 181,530 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 10 | ||||||||
Net debt | (39,250,950) | (29,049,253) | |||||||
Cash flow | |||||||||
Cash from operating activities | 16,423,575 | 10,009,498 | |||||||
CAPEX | (5,605,285) | (11,664,750) | |||||||
Cash from investing activities | (9,764,533) | (5,633,874) | |||||||
Cash from financing activities | (8,774,012) | (956,561) | |||||||
FCF | 18,207,263 | 13,460,118 | |||||||
Balance | |||||||||
Cash | 41,299,735 | 38,582,277 | |||||||
Long term investments | 344,614 | 350,450 | |||||||
Excess cash | 37,130,398 | 34,783,280 | |||||||
Stockholders' equity | 160,701,178 | 163,542,919 | |||||||
Invested Capital | 128,917,764 | 132,954,182 | |||||||
ROIC | 11.17% | 11.49% | |||||||
ROCE | 9.36% | 9.02% | |||||||
EV | |||||||||
Common stock shares outstanding | 19,500 | 19,500 | |||||||
Price | 3,760.00 9.94% | 3,420.00 -22.71% | |||||||
Market cap | 73,320,000 9.94% | 66,690,000 -22.71% | |||||||
EV | 34,069,050 | 37,640,747 | |||||||
EBITDA | 23,855,325 | 23,816,278 | |||||||
EV/EBITDA | 1.43 | 1.58 | |||||||
Interest | 95,415 | 189,810 | |||||||
Interest/NOPBT | 0.61% | 1.25% |